Faster, more accurate tests for syphilis
Rapid and Ultrasensitive aptamer-based detection technologies for T. pallidum
This project aims to create a new, quick, and highly accurate test for syphilis, a bacterial infection that is becoming more common.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11159757 on NIH RePORTER |
What this research studies
Current syphilis tests can be slow, expensive, and sometimes miss the infection or give incorrect results, especially for babies. This makes it hard for people to get treated quickly and can lead to missed diagnoses. Our team is developing a new testing method that uses special molecules called aptamers, which are like tiny magnets that can find and stick to the syphilis bacteria. This new approach could lead to a simple, rapid test that can be used right where you are, without needing a complex lab.
Who could benefit from this research
Good fit: This research is focused on developing a diagnostic tool for individuals of all ages who may have or be at risk for Treponema pallidum infection, which causes syphilis.
Not a fit: Patients who do not have or are not at risk for syphilis would not directly benefit from this specific diagnostic development.
Why it matters
Potential benefit: If successful, this new test could provide a much faster and more reliable way to diagnose syphilis, helping patients get treatment sooner and preventing the spread of the infection.
How similar studies have performed: While aptamer-based detection is an innovative approach for syphilis, similar technologies have shown promise in detecting other diseases.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Salipante, Stephen J — University of Washington
- Study coordinator: Salipante, Stephen J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.